Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: Relationship with β-adrenergic receptors and the nitric oxide pathway

Hypertension

Volumn 52, Issue 2, 2008, Pages 314-321

  Giannarelli, Chiara ^a   Virdis, Agostino ^a   De Negri, Ferdinande ^a   Duranti, Emiliano ^a   Magagna, Armando ^a   Ghiadoni, Lorenzo ^a   Salvetti, Antonio ^a   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adrenergic ; Endothelium; Essential; Hypertension; NO; t PA receptors

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHENTOLAMINE; PROPANOL; PROPRANOLOL; TISSUE PLASMINOGEN ACTIVATOR; NITRIC OXIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; FOREARM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PRIORITY JOURNAL; VASODILATATION; VEIN BLOOD FLOW; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; DRUG EFFECT; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; EPINEPHRINE; FEMALE; HUMANS; HYPERTENSION; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NITRIC OXIDE; PROBABILITY; RECEPTORS, ADRENERGIC, BETA; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 49849102302     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.111559     Document Type: Article

References (41)

1. Oliver JJ, Webb DJ, Newby DE. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol. 2005;25:2470-2479.
2. Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann N Y Acad Sci. 1992;667:249-258.
3. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S. Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP. Salvetti A, Schiffrin EL, Taddei S, Webb DJ. Endothelial function and dysfunction. Part 1: methodologic issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:7-17.
4. Giannarelli C, De Negri F, Virdis A, Ghiadoni L, Cipriano A, Magagna A, Taddei S. Salvetti A. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. Hypertension. 2007;49:878-884.
5. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97:2222-2229.
6. Hrafnkelsdottir T, Wall U. Jern C. Jern S. Impaired capacity for endogenous fibrinolysis in essential hypertension. Lancet. 1998;352: 1597-1598.
7. Robinson SD. Ludlam CA, Boon NA, Newby DE. Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease. Arterioscler Thromb Vasc Biol. 2007;27:1651-1656.
8. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363-368.
9. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol. 2000;65: 357-369.
10. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724-728.
11. Jern C, Selin L, Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost. 1994;72:285-291.
12. Chandler WL, Levy WC, Stratton JR. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine. Circulation. 1995;92: 2984-2994.
13. Chandler WL, Levy WC, Veith RC, Stratton JR. A kinetic model of the circulatory regulation of tissue plasminogen activator during exercise, epinephrine infusion, and endurance training. Blood. 1993;81:3293-3302.
14. Hrafnkelsdottir T, Gudnason T, Wall U, Jern C, Jern S. Regulation of local availability of active tissue-type plasminogen activator in vivo in man. J Thromb Haemost. 2004;2:1960-1968.
15. van Zonneveld AJ, Veerman H, Pannekoek H. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. J Biol Chem. 1986;261:14214-14218.
16. Ranby M. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta. 1982;704:461-469.
17. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
18. Taddei S, Ghiadoni L, Virdis A, Buralli S, Salvetti A. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation. 1999;100:1400-1405.
19. Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, Magagna A, Bernini G, Salvetti G, Taddei S, Salvetti A. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol. 2001;38:1106-1115.
20. Schultz K, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 1977;265:750-751.
21. Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJ. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol. 1998;32:117-122.
22. Taddei S, Salvetti A, Pedrinelli R. Persistence of sympathetic-mediated forearm vasoconstriction after alpha-blockade in hypertensive patients. Circulation. 1989;80:485-490.
23. Taddei S, Salvetti A, Pedrinelli R. Ouabain vasoconstricts human forearm arterioles through alpha-adrenergic stimulation. J Hypertens. 1988; 6(suppl):S357-S359.
24. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003;28:916-931.
25. Iaccarino G, Cipolletta E, Fiorillo A, Annecchiarico M, Ciccarelli M, Cimini V, Koch WJ, Trimarco B. Beta(2)-adrenergic receptor gene delivery to the endothelium corrects impaired adrenergic vasorelaxation in hypertension. Circulation. 2002;106:349-355.
26. Gros R, Chorazyczewski J, Meek MD, Benovic JL, Ferguson SS, Feldman RD. G-protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension. 2000;35:38-42.
27. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev. 2001;53:319-356.
28. Ridderstrale W, Ulfhammer E, Jern S, Hrafnkelsdottir T. Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapy. Hypertension. 2006;47:686-691.
29. Fox KA, Robison AK, Knabb RM, Rosamond TL, Sobel BE, Bergmann SR. Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation. 1985;72:1346-1354.
30. Newby DE, Wright RA, Dawson P, Ludlam CA, Boon NA, Fox KA, Webb DJ. The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc Res. 1998;38:485-492.
31. Schlaich MP, Ahlers BA, Parnell MM, Kaye DM. Beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine. J Hypertens. 2004;22: 1917-1925.
32. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO III, Panza JA. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation. 1998;97:851-856.
33. Garovic VD, Joyner MJ, Dietz NM, Boerwinkle E, Turner ST. Beta(2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol. 2003;546: 583-589.
34. Ferro A, Coash M, Yamamoto T, Rob J, Ji Y, Queen L. Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt. Br J Pharmacol. 2004;143: 397-403.
35. Brown NJ, Gainer JV, Murphey LJ, Vaughan DE. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclo-oxygenase-independent pathway. Circulation. 2000;102:2190-2196.
36. Taddei S, Versari D, Cipriano A, Ghiadoni L, Galetta F, Franzoni F, Magagna A, Virdis A, Salvetti A. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol. 2006;48:508-515.
37. Muldowney JA III, Painter CA, Sanders-Bush E, Brown NJ, Vaughan DE. Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid. Thromb Haemost. 2007;97:263-271.
38. Tranquille N, Emeis JJ. On the role of calcium in the acute release of tissue-type plasminogen activator and von Willebrand factor from the rat perfused hindleg region. Thromb Haemost. 1991;66:479-483.
39. Hegeman RJ, van den Eijnden-Schrauwen Y, Emeis JJ. Adenosine 3′:5′-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Thromb Haemost. 1998;79:853-858.
40. Brown NJ, Nadeau JH, Vaughan DE. Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin. Thromb Haemost. 1997;77:522-525.
41. Poli KA, Toiler GH, Larson MG, Evans JC, Sutherland PA, Lipinska I, Mittleman MA, Muller JE, D'Agostino RB, Wilson PW, Levy D. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation. 2000;101:264-269.